• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AZIYO BIOLOGICS INC. CORMATRIX ECM FOR CAROTID REPAIR; PATCH, PLEDGET AND INTRACARDIAC - DXZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AZIYO BIOLOGICS INC. CORMATRIX ECM FOR CAROTID REPAIR; PATCH, PLEDGET AND INTRACARDIAC - DXZ Back to Search Results
Model Number CMCV-072-606
Device Problem Off-Label Use (1494)
Patient Problems Stenosis (2263); Thrombosis/Thrombus (4440); Restenosis (4576)
Event Type  Injury  
Manufacturer Narrative
Manufacturing review of the cormatrix ecm for carotid repair device history record could not be completed as the lot/serial number was not provided.It is noted that the usage of the cormatrix ecm for carotid repair, now vascure for carotid repair for forming a tubular graft and usage for arteriovenous fistula is an unapproved, off-label usage.Should the device have been used per approved indications, the instructions for use (ifu - art-20702b) provided with the finished cormatrix ecm for carotid repair device lists stenosis and thrombosis as potential complications associated with the procedure and device.Futher, the same instructions for use state in warnings & precautions, and in the suggested instructions for implantation (step #6), reflect that the edges of the device must be sutured to viable native tissue and must not be sutured to homografts, synthetic or chemically cross-linked materials.The joining of three 10cm pieces of ecm tissue does not provide suturing of device ends to viable native tissue.Should aziyo receive any additional details related to this event, a supplemental report will be filed.
 
Event Description
As part of the post market surveillance process, this prospective pilot case study report published in the journal of vascular access 1-7.2019 titled "using cormatrix for partial and complete (re)construction of arteriovenous fistulas in haemodialysis patients: (re)construction of arteriovenous fistulas with cormatrix" was reviewed.This article provides the results of six (6) patients who underwent surgery between may 2016 and july 2018 for vascular access reconstruction due to thrombosis of unsalvageable arteriovenous fistulas, patients with high-flow arteriovenous fistulas and patients with microvasculature in which autologous arteriovenous fistulas did not mature.This report is focused on patient #2 (per publication table 1: patient demographics) where a (b)(6) yr.Old male with thrombosed radiocephalic arteriovenous fistula (avf) with ptfe graft on left upper arm.The surgeon utilized a tunneling device and a three (3) pieces of 2cm x 10cm cormatrix ecm for carotid repair (now aziyo biologics model #: cmcv-072-606; lot #: unknown) off-label to create an 30cm (6mm diameter) loop between brachial artery and basilicvein with additional outflow to cephalic vein following excision of ptfe graft.At 5 months post-op, stenosis of the cormatrix venous anastomosis and avf thrombosis resulting in a percutaneous tea + pta.At 6 months post-op, stenosis of the cormatrix and at 10 months stenosis recurred at venous anastomosis and avf thrombosis resulting in a percutaneous tea + pta.At 17 months post-op, stenosis of cormatrix anastomosis with basilic vein treated with pta and insertion of venous stent.At 19 months avf thrombosis due to hypotension treated with percutaneous tea, and placement of additional venous stent.Finally at 21 months avf thrombosis because of relative in-stent stenosis, relative cormatrix stenosis at punction area and hypotension treated with percutaneous tea, pta of entire avf and deb of in-stent stenosis.Performed.Graft remained implanted through article follow-up period of 24 months.Attempts to contact corresponding author have been unsuccessful for any additional information.Should any additional information be received a follow-up report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CORMATRIX ECM FOR CAROTID REPAIR
Type of Device
PATCH, PLEDGET AND INTRACARDIAC - DXZ
Manufacturer (Section D)
AZIYO BIOLOGICS INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer (Section G)
AZIYO BIOLOGICS INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer Contact
michael hennick
1100 old ellis road
ste 1200
4705144023
MDR Report Key10744177
MDR Text Key213420179
Report Number3005619880-2020-00056
Device Sequence Number1
Product Code DXZ
UDI-Device Identifier00859389005089
UDI-Public00859389005089
Combination Product (y/n)N
Reporter Country CodeSI
PMA/PMN Number
K111187
Number of Events Reported5
Summary Report (Y/N)Y
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 10/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCMCV-072-606
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/05/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-